NIH-funded research Career grant

Investigating how antibiotics affect gut bacteria and depression

Official title: A Model of Antibiotic-induced Gut Dysbiosis and Depressive Symptomatology

Funded at University of Nebraska Omaha · NIH-11055356 · Data updated 2026-11-12

This study is looking at how antibiotics might change the bacteria in our gut and how that could affect feelings of depression, using marmosets to help us understand this connection better and explore possible treatments like fecal transplants.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionUniversity of Nebraska Omaha
NIH-funded
Lab location1 site (Omaha, United States)
Project startApril 1, 2022
Project endMarch 31, 2027
Funding year2025
Award (this year)$126,738
NIH project number5K01OD030514-04
Project IDNIH-11055356 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have experienced depression following antibiotic treatment.

Less likely to help

Patients who have not been treated with antibiotics or do not suffer from depression may not benefit from this research.

What this research studies

This research explores the connection between gut bacteria and depression, particularly how antibiotics may lead to changes in gut microbiome and contribute to depressive symptoms. Using a nonhuman primate model, the common marmoset, the study will examine how antibiotic treatment alters gut bacteria and impacts behavior. The research aims to understand the mechanisms behind these changes and evaluate potential treatments, such as fecal microbiota transplantation, to alleviate depression caused by antibiotic use.

Why it matters

Potential benefit: If successful, this research could lead to new treatment strategies for depression linked to antibiotic use.

How similar studies have gone: While the specific approach using nonhuman primates is novel, there is emerging evidence suggesting that gut microbiome alterations can influence mental health outcomes.

Where this research is happening

  • University of Nebraska Omaha
    Omaha, United States
    Active

Researchers

  • Principal investigator: Clayton, Jonathan Brent — University of Nebraska Omaha
  • Study coordinator: Clayton, Jonathan Brent

Related research

Other NIH-funded projects on the same topics.

  • Microbial Dysbiosis and Its Role in Pancreatic Cancer

    A doctor-researcher team at Northwestern University is studying how gut bacteria influence pancreatic cancer and its response to immunotherapy to find new ways to help patients.

    NIH research Northwestern University · Chicago, United States · NIH-11624054

  • From Symbiosis to Dysbiosis: How Resolving Inflammation Could Restore Your Mouth’s Balance

    This grant explores how turning off the harmful inflammation in periodontitis and promoting natural healing could help restore the mouth’s healthy balance.

    NIH research Ada Forsyth Institute, INC. · Somerville, UNITED STATES · NIH-11621747

  • Antibiotics, gut health, and skin reactions in kids

    A small study in children will look at whether antibiotic use and gut bacteria play a role in hives and related symptoms that children sometimes get after antibiotics.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11603169

  • Novel therapeutic to protect the gut after radiation

    A new GI-directed treatment given after radiation exposure may reduce gut damage and improve survival in people exposed to high-dose radiation.

    NIH research Columbia University Health Sciences · New York, United States · NIH-11572662

  • A new GI-focused treatment to reduce radiation damage after exposure

    A potential GI-targeted therapy given after radiation exposure may help protect the gut and improve survival in people affected by radiation injuries.

    NIH research Columbia University Health Sciences · New York, United States · NIH-11572658

  • How a mouth bacterium might fuel gum disease and heart risk

    A small study will look at how a bacterium in the mouth that makes a reactive chemical (methylglyoxal) could drive gum inflammation and changes in the mouth’s bacteria, possibly linking to heart disease.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-11564245

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.